Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-3-26
pubmed:abstractText
To distinguish adverse events related to ribavirin therapy from those attributable to severe acute respiratory syndrome (SARS), and to determine the rate of potential ribavirin-related adverse events.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0277-0008
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
494-503
pubmed:meshHeading
pubmed-meshheading:17381375-Adrenal Cortex Hormones, pubmed-meshheading:17381375-Adult, pubmed-meshheading:17381375-Adverse Drug Reaction Reporting Systems, pubmed-meshheading:17381375-Anemia, pubmed-meshheading:17381375-Antiviral Agents, pubmed-meshheading:17381375-Bradycardia, pubmed-meshheading:17381375-Canada, pubmed-meshheading:17381375-Cohort Studies, pubmed-meshheading:17381375-Disease Outbreaks, pubmed-meshheading:17381375-Dose-Response Relationship, Drug, pubmed-meshheading:17381375-Female, pubmed-meshheading:17381375-Humans, pubmed-meshheading:17381375-Injections, Intravenous, pubmed-meshheading:17381375-Magnesium Deficiency, pubmed-meshheading:17381375-Male, pubmed-meshheading:17381375-Medical Records Systems, Computerized, pubmed-meshheading:17381375-Middle Aged, pubmed-meshheading:17381375-Retrospective Studies, pubmed-meshheading:17381375-Ribavirin, pubmed-meshheading:17381375-Severe Acute Respiratory Syndrome, pubmed-meshheading:17381375-Tetany, pubmed-meshheading:17381375-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
pubmed:affiliation
Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada. mmuller@mtsinai.on.ca
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't